GE HealthCare Technologies Service — Effects of derivatives not designated as hedging instruments increased by 200.0% to $3.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 25.0%, from $4.00M to $3.00M.
High volatility here suggests the company is taking speculative or unhedged market risks that impact reported net income.
This represents the gains or losses on derivative contracts that do not qualify for hedge accounting treatment. These in...
Often reported as 'Mark-to-market adjustments' for non-designated derivatives.
gehc_segment_service_effects_of_derivatives_not_designated_as_hedging_instruments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | -$11.00M | -$5.00M | $16.00M | $2.00M | $1.00M | -$9.00M | $8.00M | -$3.00M | $1.00M | $7.00M | -$14.00M | $4.00M | $12.00M | -$3.00M | $3.00M |
| QoQ Change | — | — | — | — | — | +54.5% | +420.0% | -87.5% | -50.0% | <-999% | +188.9% | -137.5% | +133.3% | +600.0% | -300.0% | +128.6% | +200.0% | -125.0% | +200.0% |
| YoY Change | — | — | — | — | — | — | — | — | +109.1% | -80.0% | -50.0% | -250.0% | +0.0% | +177.8% | -275.0% | +233.3% | >999% | -142.9% | -25.0% |